Clinical TrialsSearch results
Number of results: 818
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Phase I study of iPS-NKT cell intra-arterial infusion therapy in patients with recurrent or advanced head and neck cancer
- Patients with recurrent or advanced head and neck squamous cell carcinoma
- Iinuma Tomohisa
- 2020-09-11
Other
- A phase I study of niraparib and pimitespib in patients with solid tumor
- unresectable recurrent solid tumor
- Naito Yoichi
- 2022-07-02
Other
- A phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer
- Breast cancer
- Kobayashi Kana
- 2019-02-25
Other
- A phase I/II study of hepatic arterial 5-flurouracil (5FU) combined with intravenous irinotecan hydrochloride (CPT-11) for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI)
- Metastatic colorectal cancer isolated in the liver
- Japan Clinical Oncology Group(JCOG)
- 2005-08-08
Other
- A Phase Ib/II study of regorafenib and nivolumab plus chemotherapy in patients with unresectable advanced/recurrent gastric/gastroesophageal junction/esophageal adenocarcinoma
- unresectable advanced/recurrent gastric/gastroesophageal junction/esophageal adenocarcinoma
- Kawazoe Akihito
- 2022-05-25
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II randomized trial in completely resected Non-Small-Cell Lung Cancer comparing paclitaxel / carboplatin with docetaxel / cisplatin TORG0503
- Non-Small-Cell Lung Cancer
- Thoracic Oncology Research Group (TORG)
- 2008-07-11
Other
- A Phase II study of docetaxel (T) and cyclophosphamide(C) as adjuvant chemotherapy for patients with high risk, node negative, early stage breast cancer
- Breast cancer
- Japan East Cancer Center Breast Cancer Consortium
- 2006-10-01
Other
- A phase II study of gemcitabine and S-1 combination therapy for metastatic pancreatic cancer
- Metastatic pancreatic cancer
- National Cancer Center Hospital, Hepatobiliary and Pancreatic Oncology Division
- 2005-10-01
Other
- A phase II study of gemcitabine in pancreatic endocrine tumor
- pancreatic endocrine tumor
- National Cancer Center Hospital
- 2008-11-07